Get alerts for new trials in your area by subscribing now
Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
for
Glioblastoma Multiforme
Location: Montreal, Calgary
Sponsor: Bassam Abdulkarim
Sex: All
Age: 18 - 70
Code: NCT02928575
Phase2, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Chicoutimi, New York NY, Summit NJ, Montreal,